Kestra Medical CFO granted 44,118 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies Chief Financial Officer Mahboob Vaseem acquired 44,118 Common Shares on July 15, 2026, at 0.0000 per share, upon vesting of performance-based RSUs granted on July 17, 2025 after achievement of specified goals. Following this award, he directly owns 112,079 Common Shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares F1 | 44,118 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Key Figures
Key Terms
performance-based RSUs financial
PSUs financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Kestra Medical (KMTS) CFO Mahboob Vaseem report on this Form 4?
What type of security was involved in Mahboob Vaseem’s Kestra Medical (KMTS) Form 4?
How were the performance conditions structured for the Kestra Medical (KMTS) PSUs reported by the CFO?
AI-generated analysis. How Rhea-AI works. Not financial advice.